KARTEAN

Table of contents:

The "KARTEAN" trademark, serial number 86202599 , was filed on 24th of February 2014 with a mark drawing code of 4000 and its transaction date is 86202599. Since 29th of May 2014, the document can be found in the L90 law office in the publication and issue section. The date when we last checked the status of this trademark was 05/29/2014.

The "KARTEAN" trademark, serial number 86202593 , was filed on 24th of February 2014 with a mark drawing code of 4000 and its transaction date is 86202593. Since 5th of June 2014, the document can be found in the L90 law office in the publication and issue section. The date when we last checked the status of this trademark was 06/05/2014.

The corresponded responsible for this trademark is MAURY M. TEPPER, III, located at TEPPER & EYSTER, PLLC, 3724 BENSON DR, RALEIGH, NC 27609-7321.

The state or country where the trademark was organized is by Novartis Ag. The legal entity type behing it is a Corporation, located at Ch-4002, Basel, zip .Other trademarks by this applicant: TIP, FARIDAK, DICLORTEC.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class052 - Detergents and Soaps
Class Status6 - Active
Status Date03/08/2014
Primary Code005
Goods codes
GS0051pharmaceutical and biological preparations for medical diagnostic use; pharmaceutical and biological preparations for medical use, namely, for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system, for the treatment of inflammatory disorders; pharmaceutical and biological preparations for medical use, namely, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; anti-fungal, anti-infective, antiviral and antibiotic preparations
PROSECUTION HISTORY
DateDescriptionTypeCode
06/05/2014 TEAS/EMAIL CORRESPONDENCE ENTERED I - Incoming Correspondence TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
06/05/2014 CORRESPONDENCE RECEIVED IN LAW OFFICE I - Incoming Correspondence CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
06/05/2014 TEAS RESPONSE TO OFFICE ACTION RECEIVED I - Incoming Correspondence TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/03/2014 NOTIFICATION OF NON-FINAL ACTION E-MAILED O - Outgoing Correspondence GNRN
06/03/2014 NON-FINAL ACTION E-MAILED F - First Action GNRT - NON-FINAL ACTION E-MAILED
06/03/2014 NON-FINAL ACTION WRITTEN R - Renewal CNRT - NON-FINAL ACTION WRITTEN
05/27/2014 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER
03/08/2014 NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM I - Incoming Correspondence NWOS
02/27/2014 NEW APPLICATION ENTERED IN TRAM I - Incoming Correspondence NWAP - NEW APPLICATION ENTERED IN TRAM


Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.